Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma-1 receptor agonist Blarcamesine.
Patricia CogramRobert M J DeaconDaniel KlamerNell ReboweJeffrey SprouseSamantha T ReyesChristopher U MisslingWalter E KaufmannPublished in: American journal of medical genetics. Part A (2022)